Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC

J Thorac Oncol. 2017 Jun;12(6):e65-e68. doi: 10.1016/j.jtho.2016.12.024. Epub 2017 Jan 16.

¹ Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
² Department of Oncology, Shanghai Pulmonary Hospital, Cancer Institute of Tongji University Medical School, Shanghai, People's Republic of China.
³ Department of Medical Oncology, Kunshan First People's Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu, People's Republic of China.
⁴ Department of Research and Development, Geneseeq Technology Inc., Toronto, Ontario, Canada.
⁵ Department of Radiotherapy, The First Affiliated Hospital of Soochow University, Soochow, Jiangsu, People's Republic of China.
⁶ Department of Oncology, Shanghai Pulmonary Hospital, Cancer Institute of Tongji University Medical School, Shanghai, People's Republic of China. Electronic address: [email protected].

No abstract available

Publication types